glp1

As management advisory firm Oliver Wyman noted in its recent study on Medicare Advantage’s (MA) woes, “history has a way of repeating itself.” And so it is with MA’s plight today. Oliver Wyman says MA plans can learn a great deal from what plans went through during the Medicare+Choice days almost thirty years ago. Oliver Wyman admonishes plans to avoid the Medicare+Choice mistakes lest MA plans suffer the same fate of many Medicare+Choice plans back then. What is Medicare+Choice and what happened? Medicare+Choice is the same program we have today but under its earlier name. While there was managed care in Medicare for a few decades, Medicare+Choice was formally established as Part C of the program via the Balanced Budget Act of 1997 (BBA). Plans were rolled out effective January 1, 1999. Medicare+Choice was renamed Medicare Advantage as part of the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) in

Your intrepid blogger is on a GLP-1. It was with great reluctance that I went on one. I have been a diabetic for about 17 years now. I tell everyone it runs in the family, which is indeed truthful. But I admit privately (and I guess publicly as of now) that a lot of my diabetes is tied to my poor eating habits and lack of exercise. I have tried a great deal over the years to keep my HbA1C below 7.0. It worked for a while with generic meds and then with one brand drug. But as I close in on my sixties, I began inching up and went above 7.0. I am a new drug skeptic. I don’t believe the Food and Drug Administration (FDA) or brand drug makers have the best interests of Americans at heart – the FDA because it is inept, the drug makers because